工程免疫学利基监视器检查点封锁响应和探测阻力机制
Ravi M Raghani1, Russell R Urie1, Jeffrey A Ma1
1Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan.
概括
来自免疫学利基的新生物标志物预测了在三阴性乳腺癌 (TNBC) 中对抗PD-1免疫疗法的反应. 这种方法可以个性化治疗,克服对免疫检查点封锁 (ICB) 的抵抗.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物标志物发现发现
背景情况:
- 反编程细胞死亡蛋白1 (anti-PD-1) 免疫疗法对三阴性乳腺癌 (TNBC) 显示出有前途.
- 在TNBC中缺乏对抗PD-1反应的预测生物标志物,这限制了许多患者的临床益处.
- 现有的免疫学利基模型支持组织形成,免疫细胞的组成类似于重要器官.
研究的目的:
- 在免疫学领域内研究动态基因表达,以确定预测对抗PD-1疗法的反应的生物标志物.
- 探索免疫学领域的潜力,以监测免疫疗法反应和了解治疗耐药性机制.
主要方法:
- 利用转移性TNBC的4T1小鼠模型来评估对抗PD-1治疗的敏感性和耐药性.
- 在多个时间点 (治疗前,治疗期间,治疗后) 进行了已建立的皮下免疫的活检.
- 分析了针对细胞类型和基因表达模式的利基活检,这表明了治疗反应或折射性.
主要成果:
- 在敏感和耐药组之间观察到骨髓细胞与淋巴细胞比率的明显变化.
- 纵向基因表达分析揭示了动态髓状细胞功能,使治疗敏感性与耐药性有所区别.
- 在开始治疗之前开发了一个利基基因特征,可以准确预测抗PD-1治疗的敏感性或耐药性.
结论:
- 免疫学利基可以提供动态生物标志物,用于预测TNBC中抗PD-1免疫治疗反应.
- 在利基领域内监测基因表达,为个性化癌症护理提供了一种新的策略.
- 这种方法有助于研究免疫疗法耐药性的机制.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
859
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
859
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Cell-mediated Immune Responses
67.8K
Overview
67.8K
Immune Response Against Viral Pathogens
764
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
764
T Cell Activation and Clonal Selection
688
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
688


